Q3 2015 13F Holders as of 30 Sep 2015
-
Type / Class
-
Equity / Common Stock, par value $0.0001 per share
-
Shares outstanding
-
126,468,243
-
Total 13F shares
-
23,545,780
-
Share change
-
+1,124,800
-
Total reported value
-
$247,934,145
-
Put/Call ratio
-
24%
-
Price per share
-
$10.53
-
Number of holders
-
87
-
Value change
-
-$6,616,775
-
Number of buys
-
47
-
Number of sells
-
38
Institutional Holders of Karyopharm Therapeutics Inc. - Common Stock, par value $0.0001 per share (KPTI) as of Q3 2015
As of 30 Sep 2015,
Karyopharm Therapeutics Inc. - Common Stock, par value $0.0001 per share (KPTI) was held by
87 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
23,545,780 shares.
The largest 10 holders included
FRANKLIN RESOURCES INC, FMR LLC, Palo Alto Investors, LLC, BlackRock Fund Advisors, MILLENNIUM MANAGEMENT LLC, Tekla Capital Management LLC, Sectoral Asset Management Inc, VANGUARD GROUP INC, CITADEL ADVISORS LLC, and BlackRock Institutional Trust Company, N.A..
This page lists
87
institutional shareholders reporting positions in this security
for the Q3 2015 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.